Workflow
PLAYMATES TOYS(00869)
icon
Search documents
彩星玩具:主要特许权协议自2027年起将不获续期
Zhi Tong Cai Jing· 2025-12-23 10:38
Core Viewpoint - 彩星玩具 (00869) will lose the rights to sell "Teenage Mutant Ninja Turtles" products after the current licensing agreement expires on December 31, 2026, which will significantly impact its revenue from these products [1] Group 1: Licensing Agreement Details - 彩星玩具国际有限公司 (PICL) has been granted rights to design, manufacture, distribute, and sell "Teenage Mutant Ninja Turtles" products under a licensing agreement with Viacom Media Networks [1] - The licensing agreement is set to expire on December 31, 2026, and PICL has been notified that it will not be renewed [1] - PICL's rights to dispose of inventory related to the licensed products will terminate 90 days after the agreement's expiration [1] Group 2: Revenue Impact - Sales revenue from licensed products accounted for approximately 8% of the group's total revenue for the year ending December 31, 2021, 13% for 2022, 77% for 2023, 47% for 2024, and 36% for the six months ending June 30, 2025 [1] Group 3: Future Opportunities - Following the expiration of the licensing agreement, the company will continue to seek and evaluate potential licensing opportunities that align with its strategic considerations [2] - The company remains committed to developing and managing its existing product lines, including "Power Rangers," "MonsterVerse," and "Winx" [2]
彩星集团(00635.HK)主要附属公司的主要特许权协议自2027年起将不获续期
Ge Long Hui· 2025-12-23 09:21
Group 1 - The core point of the news is that PICL, a wholly-owned subsidiary of 彩星玩具, will lose its rights to design, manufacture, distribute, and sell "Ninja Turtles" products after December 31, 2026, as the licensing agreement will not be renewed [1][2] - The sales revenue from licensed products accounted for approximately 8%, 13%, 77%, 47%, and 36% of 彩星玩具's total revenue for the years ending December 31, 2021, 2022, 2023, 2024, and for the six months ending June 30, 2025, respectively [1] - The sales revenue from licensed products represented about 6%, 9%, 67%, 40%, and 26% of the group's total revenue for the same periods [2] Group 2 - The termination of the licensing agreement is expected to have a significant impact on the overall financial performance of 彩星集团 due to the reliance on revenue from licensed products [2] - The company has been in discussions regarding the renewal of the licensing agreement since October 2025, but has received formal notification that it will not be renewed [1]
彩星玩具(00869):主要特许权协议自2027年起将不获续期
智通财经网· 2025-12-23 09:10
Core Viewpoint - The company, 彩星玩具, will lose its rights to sell "Ninja Turtles" products after December 31, 2026, as the current licensing agreement will not be renewed [1] Group 1: Licensing Agreement Details - 彩星玩具's subsidiary, 彩星玩具国际有限公司 (PICL), has been granted rights to design, manufacture, distribute, and sell "Ninja Turtles" products under a licensing agreement with Viacom Media Networks [1] - Negotiations for the renewal of the licensing agreement have been ongoing since October 2025, but PICL has received formal notification that the agreement will expire on December 31, 2026, without renewal [1] - The rights to dispose of inventory related to the licensed products will terminate 90 days after the agreement's expiration [1] Group 2: Financial Impact - Sales revenue from licensed products accounted for approximately 8%, 13%, 77%, 47%, and 36% of the company's consolidated revenue for the years ending December 31, 2021, December 31, 2022, December 31, 2023, December 31, 2024, and the six months ending June 30, 2025, respectively [1] Group 3: Future Opportunities - Following the expiration of the licensing agreement, the company will continue to seek and evaluate potential licensing opportunities that align with its strategic considerations [2] - The company remains committed to developing and managing its existing product lines, including "Power Rangers," "MonsterVerse," and "Winx" [2]
彩星玩具(00869) - 内幕消息 - 主要特许权协议自二零二七年起将不获续期
2025-12-23 09:03
本公佈乃彩星玩具有限公司(「本公司」,連同其附屬公司為「本集團」)根據香 港聯合交易所有限公司證券上市規則(「上市規則」)第 13.09(2)(a)條及香港法例 第 571 章證券及期貨條例第 XIVA 部之內幕消息條文(如上市規則所定義)而刊 發。 本公司董事會(「董事會」)謹此通知本公司股東(「股東」)及潛在投資者有關 本集團最新業務發展。 根據 Viacom Media Networks 作為特許權授予人(「特許權授予人」)與本集團全 資附屬公司彩星玩具國際有限公司(「PICL」)作為特許權被授權人簽訂之現行 特許權協議(「特許權協議」),PICL 獲授予設計、製造、分銷及銷售「 忍者龜 」 產品(「特許權產品」)之權利。自二零二五年十月起,雙方一直就特許權協議續 期進行磋商,惟 PICL 最近已接獲特許權授予人的正式通知,特許權協議於二零二 六年十二月三十一日屆滿後將不獲續期。因此,PICL 銷售特許權產品之權利將於二 零二六年十二月三十一日終止,而根據特許權協議,PICL 處置特許權產品存貨之權 利將於其屆滿後九十天終止。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責,對其 ...
彩星玩具(00869.HK):租约续期
Ge Long Hui· 2025-12-05 09:03
Core Viewpoint - 彩星玩具 announced a series of lease agreements for properties in Hong Kong and the UK, effective January 1, 2026, through its indirect wholly-owned subsidiary PICL [1] Group 1: Lease Agreements - The company will continue leasing properties for office, warehouse, and exhibition purposes under the same terms as current leases [1] - The first lease agreement involves PPML acting as an agent for Belmont Limited, covering a property in Hong Kong [1] - The second lease agreement also involves PPML, this time acting as an agent for Bagnols Limited, for another property in Hong Kong [1] - A third lease agreement is established with GWL as the owner for a property in the UK [1] Group 2: Shareholding Structure - PHL indirectly owns and controls approximately 50.85% of the company's shareholding, making it the major shareholder [1]
彩星玩具(00869) - 关连交易 - 租约续期
2025-12-05 08:58
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責,對其準確性 或完整性亦不發表任何聲明,並明確表示,概不對因本公佈全部或任何部份內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 PLAYAMTES TOYS LIMITED 彩星玩具有限公司* ( 於百慕達註冊成立之有限公司 ) (股份代號:869) 關連交易 租約續期 茲提述現行租約,據此,關連業主同意向本集團出租若干物業以作辦公室及倉庫之 用。現行租約將於二零二五年十二月三十一日屆滿。 董事會宣佈,於二零二五年十二月五日,本公司之間接全資附屬公司PICL作為租戶 與下方訂立該等租約,繼續向關連業主租賃以根據現行租約相同物業作辦公室、倉 庫及展覽用途: PHL間接擁有並控制本公司約50.85%之股份權益,為本公司之主要股東。因此,根 據上市規則,PPML、GWL、Belmont Limited及Bagnols Limited均為PHL之聯繋人, 因而為本公司之關連人士。 根據香港財務報告準則第16號「租賃」,本集團將於其綜合財務狀況表内將該等租 約租金總額之現值確認為使用權資產,估計價值約為港幣14,200,000元。因此,就 ...
彩星玩具(00869) - 截至2025年11月30日止月份之股份发行人的证券变动月报表
2025-12-03 07:38
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致:香港交易及結算所有限公司 公司名稱: 彩星玩具有限公司 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00869 | 說明 | | | | | | | | | 已發行股份(不包括庫存股份)數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,180,000,000 | | 0 | | 1,180,000,000 | | 增加 / 減少 (-) | | | 0 | | | | | | 本月底結存 | | | 1,180,000,000 | | 0 | | 1,180,000,000 | 第 2 頁 共 10 頁 v 1.1.1 呈交日期: 2025年12月3日 I. 法定/註冊股本變動 ...
彩星玩具(00869) - 截至2025年10月31日止月份之股份发行人的证券变动月报表
2025-11-04 09:21
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | | | 致:香港交易及結算所有限公司 公司名稱: 彩星玩具有限公司 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00869 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | HKD | | 0.01 | HKD | | 30,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 3,000,000,000 | HKD | | 0.01 | HKD | | 30,000,000 | 本月底法定/註冊股本總額: HKD 30,000,000 F ...
300869,收到FDA警告信
Zhong Guo Ji Jin Bao· 2025-10-10 16:23
Group 1 - The core issue is that 康泰医学 received a warning letter from the FDA on October 2, 2025, due to non-compliance with medical device quality system regulations during an inspection conducted from June 9 to June 12, 2025 [2] - The warning letter indicates that 康泰医学's medical devices exported to the U.S. did not meet the requirements of the U.S. federal regulations 21 CFR Part 820, which may lead to the rejection of its products until the issues are resolved [2] - 康泰医学 plans to submit a response report to the FDA detailing corrective actions and timelines, aiming to resolve the issues and lift the warning [2] Group 2 - In 2024, 康泰医学 generated sales revenue of 114 million yuan from the U.S., accounting for 23.84% of its total revenue, while in the first half of 2025, sales revenue from the U.S. was 41.89 million yuan, representing 19.26% of total revenue [2] - The company has a high export ratio, with 73.08% of its sales coming from international markets in 2024, indicating potential broader impacts from the FDA's judgment on sales in other countries [3] - As of September 16, 2025, the second-largest shareholder, 王桂丽, reduced her stake in 康泰医学 to 10% from 14.7% since 2021, indicating a significant decrease in ownership [3] Group 3 - On October 10, 康泰医学's stock closed at 16.4 yuan per share, with a market capitalization of 6.59 billion yuan [4]
彩星玩具(00869) - 截至2025年9月30日止月份之股份发行人的证券变动月报表
2025-10-02 08:55
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | | | | 狀態: 新提交 | | --- | --- | --- | --- | --- | --- | | 致:香港交易及結算所有限公司 | | | | | | | 公司名稱: | 彩星玩具有限公司 | | | | | | 呈交日期: | 2025年10月2日 | | | | | | I. 法定/註冊股本變動 | | | | | | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | 證券代號 (如上市) | 00869 | 說明 | | | | FF301 第 1 頁 共 10 頁 v 1.1.1 法定/註冊股份數目 面值 法定/註冊股本 上月底結存 3,000,000,000 HKD 0.01 HKD 30,000,000 增加 / 減少 (-) HKD 增加已發行股份(不包括庫存股份): 普通股 (AA1) 本月底結存 3,000,000,000 HKD 0.01 HKD 30,000,000 本月底法定/註冊股本總額: ...